The "Fast Money" traders share their final trades of the day.» Read More
Establishing a tax domicile abroad to avoid taxes is popular, but many US companies have failed to produce strong returns for investors.
LOS ANGELES, Aug 17- Biotech drug production techniques based on plants, which may prove to be faster, higher yielding and cheaper than current methods using mammalian cells, haven't caught on with the biggest pharmaceutical companies.
NORWICH, England, Aug 17- Pampering leafcutter ants with fragrant rose petals and fresh oranges may seem an unlikely way to rescue modern medicine, but scientists at a lab in eastern England think it's well worth trying.
Baxter International Inc. fell$. 34 or. 5 percent, to $74.41. Bristol-Myers Squibb Co. fell$. 14 or. 3 percent, to $49.68. Hospira fell$. 69 or 1.2 percent, to $55.02.
NEW YORK— A look at New York Stock Exchange 10 most-active stocks at the close of trading:. AT&T Inc. fell. 5 percent to $34.74 with 26,666,200 shares traded. Advanced Micro Devices Inc. rose 1.2 percent to $4.13 with 33,133,800 shares traded.
Baxter International Inc. fell$. 54 or. 7 percent, to $74.21. Bristol-Myers Squibb Co. fell$. 33 or. 7 percent, to $49.49. Hospira fell$. 90 or 1.6 percent, to $54.81.
LONDON, Aug 15- U.S. investors are withdrawing billions of dollars from European stocks as signs of a stalled economic recovery, compounded by the Ukraine crisis, halt the past year's scramble to buy back into the region.
U.S.stocks closed higher on Thursday at August highs despite subpar economic data around the world, and after conciliatory remarks from Putin.
NEW YORK, Aug 14- A federal judge rejected billionaire investor Steven A. Cohen's bid to dismiss lawsuits by Elan Corp and Wyeth shareholders who claimed they lost money because his firm SAC Capital Advisors LP conducted insider trading in the drugmakers' stocks.
NEW YORK, Aug 13- Biotechnology company InterMune Inc is working with financial advisers to evaluate strategic options as it braces for potential takeover interest from larger drugmakers, people familiar with the matter said.
*Sanofi, MannKind aim to launch Afrezza in U.S. in Q1 2015. PARIS/ LONDON, Aug 11- French drugmaker Sanofi is betting on inhaled insulin as an alternative option to daily injections for diabetics by signing a worldwide licensing agreement with MannKind Corp worth up to $925 million.
Pfizer confronts surge of lawsuits over Lipitor. Pharmaceutical giant Pfizer is facing a mounting number of lawsuits by women who say the company knew its blockbuster anti-cholesterol drug Lipitor was linked to a small increased risk of type-2 diabetes but never properly warned the public.
These six names are all trading at least 10 percent below their 52-week highs, and a number of other Dow stocks are less than 1 percentage point away.
Geopolitics are likely to dominate markets Friday, with traders sensitive to even small developments.
Pfizer is facing a mounting wave of lawsuits by women who allege that the company knew about possible serious side effects of its drug Lipitor.
Aug 8- Pharmaceutical giant Pfizer is facing a mounting wave of lawsuits by women who allege that the company knew about possible serious side effects of its blockbuster anti-cholesterol drug Lipitor but never properly warned the public.
Stocks fell Thursday as Wall Street echoed action in European markets and tracked Ukraine news.
*Expects key drug launches in fourth quarter despite FDA delay. Aug 7- Political opposition to tax-inversion deals will not stop Mylan Inc's purchase of some non-U.S. businesses from Abbott Laboratories, Chief Executive Heather Bresch said, even as some companies have backed away from such tax arrangements.
*Cuts top end of FY earnings forecast to $3.45/ shr from $3.60/ shr. Aug 7- Mylan Inc shaved the top end of its full-year revenue and earnings forecasts, citing delays in approval from the U.S. Food and Drug Administration for key generic drugs that it plans to launch this year.
*Walgreen to buy remaining 55 pct of Alliance Boots. *Walgreen says inversion deal not in interests of investors. Aug 6- U.S. retailer Walgreen Co said it would not use a full takeover of Europe's biggest pharmacy chain, Alliance Boots, to move its domicile overseas, following fierce criticism of such tax-cutting deals at home.